Aptose Biosciences (NASDAQ:APTO) Coverage Initiated at StockNews.com
StockNews.com began coverage on shares of Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS) in a research report issued to clients and investors on Sunday. The brokerage set a “hold” rating on the biotechnology company’s stock. Separately, HC Wainwright reiterated a “buy” rating and issued a $2.00 price objective on shares of Aptose Biosciences in […]
StockNews.com began coverage on shares of Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS) in a research report issued to clients and investors on Sunday. The brokerage set a “hold” rating on the biotechnology company’s stock. Separately, HC Wainwright reiterated a “buy” rating and issued a $2.00 price objective on shares of Aptose Biosciences in […]
